Post-Madoff, SEC Successfully Partnering with Whistleblowers to Combat Ponzi Schemes
With "Madoff: The Monster of Wall Street" releasing on Netflix, dive into some of the top ponzi schemes uncovered by whistleblowers.
Open Enrollment for Medicare Advantage Plans is Not Open Season for Fraud
The Department of Justice and whistleblowers have pursued False Claims Act cases against at least half of the top ten Medicare Part C providers.
The Anti-Money Laundering Whistleblower Program Is Strengthened
In the final days of 2022, President Biden signed improvements to the Anti-Money Laundering Whistleblower Program, to better reward whistleblowers.
A Tradition of Fraud Persists in New Types of Medicare Delivery Models
Unscrupulous medical providers, hospitals, and drug manufacturers, can and do defraud Medicare Advantage plans in the same ways they defraud “traditional” Medicare.
SEC and CFTC Whistleblower Programs Reveal Continued Success Combatting Fraud and Protecting Investors
These agencies are still confronting significant resource challenges vetting and investigating a record number of tips and adjudicating applications for whistleblower awards.
2021 IRS Whistleblower Program Numbers Fell Flat, But Hope Remains
The history of the program shows it can work. Since its inception, IRS whistleblowers have helped the U.S. Government collect $6.3+ billion from non-compliant taxpayers.
2022 John R. Phillips Leadership Award Recipient
TAF bestows the inaugural John R. Phillips Leadership Award to Neil V. Getnick for the remarkable service and leadership throughout his career.
2022 Lifetime Achievement Award Recipient
TAF bestows the 2022 Lifetime Achievement Award to Marlan Wilbanks for his remarkable service and leadership throughout his career.
2022 Whistleblower of the Year Recipient
TAF bestows the 2022 Whistleblower of the Year Award to Michael Bawduniak for his decade-long efforts in the Biogen case.
2022 Lawyers of the Year Recipients
TAF bestows the 2022 Lawyers of the Year Award to the Greene LLP team for their efforts in the Biogen case decided earlier this year.
